Loading
NASDAQHealthcareBiotechnology
Latest quote
$28.09
−$0.73 · -2.53%
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
Latest quote
$28.09
−$0.73 · -2.53%
After-hours
$28.09
$0.00 · 0.00%
Oct 8, 4:10 PM ET
Regular session · ET · Market data may be delayed.
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
Day range
Current $28.09
52-week range
Current $28.09
Regular session · ET · Market data may be delayed.
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
Day range
Current $28.09
52-week range
Current $28.09
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 |
|---|---|---|
| Research and development | 125.58M USD | 100.83M USD |
| Selling, general, and administrative | 26.5M USD | 25.3M USD |
| Operating expenses | 152.08M USD | 126.13M USD |
| Interest income | 3.39M USD | 6.41M USD |
| Interest expense | 1.52M USD | 1.49M USD |
| Depreciation and amortization | 2.5M USD | 2.1M USD |
| Operating income | −152.08M USD | −126.13M USD |
| Net income | −145.89M USD | −117.91M USD |
Company facts updated Oct 8, 2026.
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$40.00
42.40% upsideFunds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI43.73M0.00%2.3T USD0.03%$379.55-0.39%
Vanguard Morningstar Small-Cap ETFVB31.58M0.02%185.3B USD0.03%$287.65+0.23%
iShares Russell 2000 ETFIWM30.03M0.04%78.56B USD0.19%$277.63-0.03%
Vanguard Morningstar Small-Cap Value ETFVBR10.03M0.01%68.2B USD0.05%$233.95+0.77%
Vanguard Morningstar Small-Cap Growth ETFVBK8.99M0.02%44.7B USD0.05%$340.66-0.46%
iShares Russell 2000 Growth ETFIWO6.45M0.05%14.25B USD0.24%$353.14-0.63%
Schwab U.S. Small-Cap ETFSCHA5.39M0.02%21.7B USD0.03%$32.645+0.11%
Fidelity Blue Chip Growth ETFFBCG2.74M0.04%7.62B USD0.57%$63.57-1.58%Vanguard Morningstar Total Stock Market ETFVTIVanguard Morningstar Small-Cap ETFVBiShares Russell 2000 ETFIWMVanguard Morningstar Small-Cap Value ETFVBRVanguard Morningstar Small-Cap Growth ETFVBKiShares Russell 2000 Growth ETFIWOSchwab U.S. Small-Cap ETFSCHAFidelity Blue Chip Growth ETFFBCGAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
